Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Intangibles (2023 - 2025)

Historic Intangibles for bioAffinity Technologies (BIAF) over the last 3 years, with Q3 2025 value amounting to $731389.0.

  • bioAffinity Technologies' Intangibles fell 6755.85% to $731389.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $731389.0, marking a year-over-year decrease of 6755.85%. This contributed to the annual value of $775139.0 for FY2024, which is 699.88% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Intangibles stood at $731389.0, which was down 6755.85% from $745972.0 recorded in Q2 2025.
  • bioAffinity Technologies' Intangibles' 5-year high stood at $2.3 million during Q2 2024, with a 5-year trough of $731389.0 in Q3 2025.
  • For the 3-year period, bioAffinity Technologies' Intangibles averaged around $1.4 million, with its median value being $833472.0 (2023).
  • Per our database at Business Quant, bioAffinity Technologies' Intangibles surged by 1280.59% in 2024 and then plummeted by 6755.85% in 2025.
  • bioAffinity Technologies' Intangibles (Quarter) stood at $833472.0 in 2023, then dropped by 7.0% to $775139.0 in 2024, then dropped by 5.64% to $731389.0 in 2025.
  • Its last three reported values are $731389.0 in Q3 2025, $745972.0 for Q2 2025, and $760556.0 during Q1 2025.